Analytics Center of Excellence (CoE)

Pharma companies are struggling with fragmented analytics teams, limited thought leadership and inflexible operating models. Axtria’s Analytics CoE elevates client experience with a synergy of data and therapy experience, advanced analytics and integrated technology framework. Experience improved commercial outcomes and better operational turnaround-times using our nimble, flexible and scalable consultative frameworks, managed by a global pool of domain experts.

Key Differentiators


Deep Expertise in
Commercial Operations​

Weave strategy, tactics, and operations to successful outcomes with rich domain & consulting experience, and deep investments in technology.



Integrate new data sources (like EMR & Labs Data), advanced analytics and next-generation platforms into your insight building processes. Axtria’s CoE is built to support 21st century life sciences companies.​



Drive sustainable innovation and operational excellence via strong management and governance. Our principals have 15+ years of industry experience.​


Unique Talent
Transformation Ecosystem​

Partner with experienced leadership, on-site client experts and a constantly evolving global talent pool of insight generators and strategic consultants, to drive efficiency and success.


Investment in

Invest in scale with a sizable global talent bench and a pool of resources and platforms to easily support large, core-flex operations. Axtria has worked with 8 of the top 10 life sciences companies.


Experience Gleaning
Strategic Insights

Benefit from decades of experience across the biggest, most innovative pharma brands, deep understanding of major therapeutic areas and client-side experience in market research & insights.​

Customer Success Stories

Explore How Axtria Helps Life Sciences Businesses Achieve Commercial Success.

Analytics Center of Excellence
Data & Analytics Center Of Excellence (CoE) For A Global Pharma

Life sciences organizations are struggling with several factors, including fragmented analytics teams, siloed decision making, limited thought leadership, and inflexible operating ...

Strategic Course Correction For A Blockbuster Oncology Drug

A top pharma company that had done well to grow their oncology drug to a blockbuster status was struggling with understanding and achieving its full potential. Axtria provided str ...

sales analytics
Sales Force Restructuring Strategy For A New Oncology Indication Launch In The US

With the rise of specialty pharma, the interactions between sales reps and healthcare stakeholders are becoming more profound, more productive, and much more scientific. ...

Start typing and press Enter to search